Fortress Biotech (FBIO) FCF Margin Growth (1y) (2016 - 2025)
Powered by 
Analysis
Fortress Biotech (FBIO) FCF Margin Growth (1y) (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 26,102.00 |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 869.00 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 769.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 811.00 |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 19,111.00 |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 735.00 |
| Sep 30, 2025 | 9,293.00 |
| Jun 30, 2025 | -1,195.00 |
| Mar 31, 2025 | 4,594.00 |
| Dec 31, 2024 | 8,992.00 |
| Sep 30, 2024 | -7,930.00 |
| Jun 30, 2024 | 3,561.00 |
| Mar 31, 2024 | 15,304.00 |
| Dec 31, 2023 | 11,693.00 |
| Sep 30, 2023 | 21,946.00 |
| Jun 30, 2023 | 3,728.00 |
| Mar 31, 2023 | -14,643.00 |
| Dec 31, 2022 | -6,978.00 |
| Sep 30, 2022 | -16,266.00 |
| Jun 30, 2022 | -2,674.00 |
| Mar 31, 2022 | -957.00 |
| Dec 31, 2021 | -6,836.00 |
| Sep 30, 2021 | 14,158.00 |
| Jun 30, 2021 | -521.00 |
| Mar 31, 2021 | -1,823.00 |